Electrosurgical devices in gynecologic oncology: a systematic review of clinical studies

Read full text Summarise with VIRAT
Authors: Ekaterina Lazhovska, Kristina Drusany Starič, Katrina Mencin, Marina Jakimovska
Cited by: 0
References: 26

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Introduction: Electrosurgical instruments are a crucial component in the surgical treatment of gynecologic malignancies, enabling precise dissection and effective hemostasis, influencing blood loss, operative time and complication rates. Considering their importance in oncological outcomes and increasing variety, comparative data in the literature remains limited. Our aim is to comprehensively assess and compare clinical outcomes across electrosurgical modalities in gynecologic cancer surgery. Methods: Following PRISMA guidelines, we performed a systematic search of three electronic databases (PubMed, Cochrane Library, Scopus). Eligible studies since 2005 enrolled women (≥18 years) undergoing surgery for gynecological neoplasms, in which electrosurgical devices were used. Clinically relevant outcomes, such as intraoperative blood loss, operative time, perioperative complication rates, surgeon's experience and length of hospital stay were compared. Results: 359 publications were reviewed after literature search, 10 of them fitted the inclusion criteria, 1 additional publication was added after references review. Most of the studies (36.4%) evaluated cervical cancer only, followed by studies that included both cervical and endometrial cancer (27.3%), while 18.2% of the studies focused on endometrial and ovarian cancer each. Majority of the articles (82%) evaluated advanced electrosurgical devices alone or in comparison with standard electrosurgery or conventional methods. LigaSure was the most commonly used advanced electrosurgical device, followed by THUNDERBEAT, PlasmaJet™, PlasmaKinetic tissue management system and ERBE BiClamp® forceps. All of the studies assessed more than one perioperative outcome, with the most common being estimated blood loss, operative time and duration of hospitalization. Discussion: Despite heterogeneous design and outcomes, most findings suggest that advanced electrosurgical devices are associated with mostly better perioperative outcomes in oncological patients undergoing surgery. It can be concluded that the effectiveness of the device and the appropriate instrument selection differs between malignancies, depending on the cancer type and operative procedure performed. Given the diversity of the studies we believe that additional well-designed studies using standardized outcomes sets are needed.

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Uterine Myomas and Treatments Hemostasis and retained surgical items

Publication details

Journal / source
Frontiers in Surgery
Volume
13
Pages
1772803–1772803
Publication date
23 March 2026
Language
EN